Tag:
Medication

Results for the category
Medication
in the

Santé Vous Bien Blog

Health issues

Health chronicle: Rifampin

Rifampin is the only antibiotic known to decrease the effectiveness of oral contraceptives, requiring the use of an additional contraceptive method during treatment and several weeks after stopping treatment.

November 8, 2018
Health issues

Health Questions: Inhaled Medication

A clear reminder of the recommended order to optimize the effectiveness of inhaled treatments and medications for people living with cystic fibrosis, from bronchodilators to antibiotics.

November 5, 2018
Health issues

Health Questions 2

Clear answers from a pulmonologist to frequently asked questions from adults living with cystic fibrosis about thrush, venous catheters, alcohol, and some medications.

February 1, 2023
Research

Research and Cystic Fibrosis: 2022 Update

This 2022 update presents the major advances in cystic fibrosis research, marked by the arrival of CFTR modulators (ETI/Trikafta), their major benefits, emerging clinical challenges and research paths for ineligible people.

February 1, 2023
Psychology

CFTR modulators and mental health

This article takes stock of the possible links between CFTR modulators, in particular Trikafta, and mental health, by exploring indirect psychological effects, possible biological mechanisms, drug interactions, and the importance of individualized follow-up.

February 1, 2023
Interviews and testimonies

The approval of Trikafta

The addition of Trikafta to the RAMQ in September 2021 marks a major advance for cystic fibrosis in Quebec by making available a treatment that acts on the cause of the disease for eligible people.

January 25, 2022
Results for the category
Medication
in

News

News

Health Canada approves SYMDEKO™

Health Canada has approved SYMDEKO™, a treatment that targets the genetic cause of cystic fibrosis, opening access to a new treatment option for some people as young as 12 years of age, subject to reimbursement.

June 28, 2018
Research

Cystic Fibrosis Research: Major Advances and Persistent Challenges in 2015

A review of the scientific advances presented in 2015 highlights the progress of therapies targeting CFTR, in particular Orkambi, while highlighting the challenges related to their effectiveness, accessibility and cost.

January 27, 2016

Thanks to Our Partners